Edifice Health is a biotechnology company specializing in quantifying and addressing systemic chronic inflammation (SCI), a key factor in ageing and various age-related diseases. Leveraging insights from the Stanford 1,000 Immunomes Project, they have developed innovative tools like the iAge® test and SCI Index®, which provide actionable metrics for immune health and ageing. Through collaborations with academia, healthcare, and industry, Edifice Health aims to advance personalized health strategies, improve disease prevention, and promote healthier ageing by tackling inflammation at its core.